264 related articles for article (PubMed ID: 4000338)
1. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Petersen J; Stewart RD; Catto GR; Edward N
Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
Johnson CA; Zimmerman SW; Bayer W; Craig WA
Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
[TBL] [Abstract][Full Text] [Related]
6. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
7. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA
Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
9. Group JK corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.
Pierard D; Lauwers S; Mouton MC; Sennesael J; Verbeelen D
J Clin Microbiol; 1983 Oct; 18(4):1011-4. PubMed ID: 6630457
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
Klaus G; Schäfer F; Querfeld U; Soergel M; Wolf S; Mehls O
Adv Perit Dial; 1992; 8():302-5. PubMed ID: 1361812
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal hydrocortisone in eosinophilic peritonitis associated with continuous ambulatory peritoneal dialysis.
Leung AC; Orange G; Henderson IS
Br Med J (Clin Res Ed); 1983 Mar; 286(6367):766. PubMed ID: 6402243
[No Abstract] [Full Text] [Related]
12. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.
Rubin J; Ray R; Barnes T; Bower J
Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
Johnson CA; Welling PG; Zimmerman SW
Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
[TBL] [Abstract][Full Text] [Related]
15. [Peritonitis in renal failure patients treated by continuous ambulatory peritoneal dialysis. Treatment by intraperitoneal administration of a group M penicillin].
Pierre D; Barthez JP; Geslin N; Calamy G; Borderon E
Presse Med; 1985 Jun; 14(26):1413-6. PubMed ID: 3161046
[TBL] [Abstract][Full Text] [Related]
16. [Peritonitis during continuous ambulatory peritoneal dialysis. Lavage treatment or not? A prospective study].
De Groc F; Rottembourg J; Jacq D; Jarlier V; N'Guyen J; Legrain M
Nephrologie; 1983; 4(1):24-7. PubMed ID: 6843764
[TBL] [Abstract][Full Text] [Related]
17. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
18. Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis.
Lempert KD; Jones JM
Arch Intern Med; 1982 Mar; 142(3):577-8. PubMed ID: 7065793
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis ].
de Fremont JF; Schmit JL; Thomas D; Coevoet B; Eb F; Laurence G; Orfila J; Fournier A
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):581-4. PubMed ID: 6750528
[TBL] [Abstract][Full Text] [Related]
20. The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
Scott Med J; 1984 Apr; 29(2):117-8. PubMed ID: 6531683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
